Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing. The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST. Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival. The ongoing trial is evaluating if MaaT033 can increase survival by preventing complications such as GVHD. Narjust Florez, MD, FASCO, discusses key considerations for oncology nurses caring for these patients. Learn what the study showed about shorter courses of post-mastectomy radiation combined with breast reconstruction. The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains. New research highlights the need for “early and equitable” integration of palliative care for patients with myeloma. The study investigators say the 5-year survival rate "dramatically exceeds historical standards." Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer. Researchers evaluated the renal status of more than 250 patients receiving TKIs in a chronic myeloid leukemia clinic. Researchers presented the results of the observational study at the 2024 SOHO Meeting. Research presented at the Annual Meeting of the Society of Hematologic Oncology provided insights on outcomes and risks. An analysis of the RESPONSE and RESPONSE-2 studies further supports the benefit of ruxolitinib in these patients. Dr. Bose shared his insights at the Twelfth Annual Society of Hematologic Oncology Meeting in Houston. A new study highlights the importance of effective management and close monitoring of GVHD. A study of more than 10,000 patients illuminated the characteristics and needs of patients who are in remission. Learn how an innovative rehabilitation model improved clinical outcomes and patient satisfaction with nursing care. Learn about the diverse unmet needs and potential solutions related to the experiences of patients and caregivers. New research shows that major depressive disorder is associated with certain outcomes in this population of patients.